8.05
-0.05 (-0.62%)
| Penutupan Terdahulu | 8.10 |
| Buka | 7.96 |
| Jumlah Dagangan | 127,133 |
| Purata Dagangan (3B) | 369,014 |
| Modal Pasaran | 557,493,952 |
| Harga / Jualan (P/S) | 20.30 |
| Harga / Buku (P/B) | 0.750 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Aug 2025 - 8 Aug 2025 |
| Margin Operasi (TTM) | -703.66% |
| EPS Cair (TTM) | -3.16 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -48.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.12% |
| Nisbah Semasa (MRQ) | 14.86 |
| Aliran Tunai Operasi (OCF TTM) | -180.22 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -108.88 M |
| Pulangan Atas Aset (ROA TTM) | -21.69% |
| Pulangan Atas Ekuiti (ROE TTM) | -37.07% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menurun | Menurun |
| Biotechnology (Global) | Menurun | Menurun | |
| Stok | Bicycle Therapeutics plc | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 1.0 |
| Purata | 1.75 |
|
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 1.46% |
| % Dimiliki oleh Institusi | 93.79% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 32.00 (RBC Capital, 297.52%) | Beli |
| Median | 19.50 (142.24%) | |
| Rendah | 14.00 (B. Riley Securities, 73.91%) | Pegang |
| Purata | 21.50 (167.08%) | |
| Jumlah | 4 Beli, 2 Pegang | |
| Harga Purata @ Panggilan | 8.95 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Morgan Stanley | 06 May 2025 | 17.00 (111.18%) | Pegang | 7.40 |
| B. Riley Securities | 02 May 2025 | 14.00 (73.91%) | Pegang | 9.30 |
| JMP Securities | 02 May 2025 | 22.00 (173.29%) | Beli | 9.30 |
| Needham | 02 May 2025 | 29.00 (260.25%) | Beli | 9.30 |
| 09 Apr 2025 | 30.00 (272.67%) | Beli | 6.88 | |
| RBC Capital | 02 May 2025 | 32.00 (297.52%) | Beli | 9.30 |
| Barclays | 01 May 2025 | 15.00 (86.34%) | Beli | 9.08 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 22 May 2025 | Pengumuman | Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting |
| 05 May 2025 | Pengumuman | Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 01 May 2025 | Pengumuman | Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results |
| 29 Apr 2025 | Pengumuman | Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025 |
| 02 Apr 2025 | Pengumuman | Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 01 Apr 2025 | Pengumuman | Bicycle Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference |
| 27 Mar 2025 | Pengumuman | Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments |
| 05 Mar 2025 | Pengumuman | Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |